Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Finlabo SIM Spa
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aastrom Biosciences Inc to acquire Sanofi 's Cell Therapy and Regenerative Medicine Business

Monday, 21 Apr 2014 08:31am EDT 

Aastrom Biosciences Inc:Agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business.Purchase price of $6.5 mln, with $4 mln payable in cash at closing and $2.5 mln payable in form of a promissory note. 

Company Quote

26 Feb 2015